Latest Strategic Capital Raising News

Rapid Critical Metals has successfully raised A$14 million through a two-tranche placement, backed by top-tier institutional investors, to fund its acquisition of the Webbs Consol Project and accelerate silver exploration in NSW and Canada.

Tivan Limited has raised $15 million through a strategic share placement led by ETFS Capital, positioning the company for key project acquisitions and development in fluorite and tungsten mining.

Paladin Energy Ltd has launched a significant A$300 million underwritten equity raising to advance its Patterson Lake South uranium project and support the ramp-up of its Langer Heinrich Mine, reinforcing its position in the global uranium market.

Paladin Energy has launched a fully underwritten A$300 million equity raising to advance its Patterson Lake South uranium project, aiming for a Final Investment Decision and first production by 2031.

Summit Minerals announces a $1.67 million capital raise through a Placement and a fully underwritten Rights Issue, aiming to accelerate exploration in Brazil and pursue new project opportunities.

Critical Resources Limited has raised $1.8 million through a strategic placement to fund maiden drilling programs at its gold-antimony projects in New South Wales and New Zealand, signaling a pivotal step in its exploration journey.

Ionic Rare Earths has launched a $7 million capital raise through a renounceable rights issue and placement, aiming to accelerate its magnet recycling projects and expand operations internationally.

Flynn Gold has announced a renounceable rights issue to raise up to $3 million, aiming to accelerate exploration at its promising Golden Ridge project in Tasmania.

Cobram Estate Olives Limited has launched a $185 million capital raising to fund a major expansion of its vertically integrated olive oil operations in California, aiming to become the largest olive farmer in the US.

Cobram Estate Olives has secured $175 million through an institutional placement to accelerate its expansion in the US, aiming to increase its Californian olive groves to 3,600 hectares and boost olive oil production significantly by 2027.

Tasmea Limited has completed a fully underwritten A$43 million institutional placement, aiming to accelerate acquisitions, reduce debt, and enhance its chances of joining the ASX 300 Index.

Alterity Therapeutics has raised A$20 million through a strategic placement to advance its promising ATH434 treatment for Multiple System Atrophy, backed by encouraging Phase 2 trial results. The capital injection strengthens the company’s balance sheet as it prepares for regulatory discussions with the FDA.